Trial intelligence / Profile preview

Norepinephrine pharmacokinetics and pharmacodynamics before and during general anesthesia in healthy volunteers

2020-005886-15Phase 4Active

Sponsor
University Medical Center Groningen
Start
Apr 2021
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of norepinephrine, propofol and remifentanil, sponsored by University Medical Center Groningen. Primary endpoint: Relationship between plasma norepinephrine concentrations and hemodynamics while awake. Started Apr 2021; status: active.

02

Drugs

norepinephrinepropofolremifentanil

Beyond the preview

Go deeper on 2020-005886-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-005886-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call